Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
World Neurosurg ; 188: e223-e232, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38777318

RESUMO

OBJECTIVE: Surgery is a good treatment option for drug-resistant temporal lobe epilepsy (TLE). 2-deoxy-2-(18F) fluoro-D-glucose (FDG) positron emission tomography (PET) is used to detect epileptic foci as hypometabolic lesions in presurgical evaluation. Visual field defects (VFDs) in the contralateral homonymous upper quadrant are common postoperative complications in TLE. This study aimed to quantify VFDs using pattern deviation probability plots (PDPPs) and examine the effect of hypometabolism in FDG-PET on VFDs. METHODS: This study included 40 patients. Both visual fields were assessed using the Humphrey field analyzer preoperatively and 3 months and 2 years postoperatively. PDPPs with <0.5% confidence level counted in the contralateral homonymous upper quadrant. FDG-PET results were compared between groups with (15 patients) and without (24 patients) hypometabolism in the optic radiation. RESULTS: All 40 patients were evaluated by Humphrey field analyzer at 3 months postoperatively and 39 at 2 years postoperatively. The incidence of VFDs 3 months postoperatively was 35/40 (87.5%), and 17/40 (42.5%) patients had severe VFDs. In cases of surgery on the left temporal lobe, ipsilateral eyes appeared to be more significantly affected than contralateral eyes. VFDs were more severe in patients with FDG hypometabolism than in those without hypometabolism in posteromedial temporal and medial occipital cortex (P < 0.01); however, 85% of patients with FDG hypometabolism had a reduced VFD 2 years postoperatively. CONCLUSIONS: PDPP counting is useful for quantifying VFDs. Preoperative dysfunction indicated by preoperative FDG-PET in the posteromedial temporal and medial occipital cortex could enhance VFDs early after TLE surgery.


Assuntos
Epilepsia do Lobo Temporal , Fluordesoxiglucose F18 , Lobo Occipital , Tomografia por Emissão de Pósitrons , Complicações Pós-Operatórias , Lobo Temporal , Humanos , Epilepsia do Lobo Temporal/cirurgia , Epilepsia do Lobo Temporal/diagnóstico por imagem , Epilepsia do Lobo Temporal/metabolismo , Feminino , Masculino , Adulto , Tomografia por Emissão de Pósitrons/métodos , Estudos Retrospectivos , Lobo Occipital/diagnóstico por imagem , Lobo Occipital/metabolismo , Lobo Occipital/cirurgia , Lobo Temporal/metabolismo , Lobo Temporal/diagnóstico por imagem , Lobo Temporal/cirurgia , Seguimentos , Pessoa de Meia-Idade , Adulto Jovem , Complicações Pós-Operatórias/metabolismo , Complicações Pós-Operatórias/diagnóstico por imagem , Campos Visuais/fisiologia , Compostos Radiofarmacêuticos , Adolescente , Transtornos da Visão/etiologia , Transtornos da Visão/diagnóstico por imagem , Transtornos da Visão/metabolismo , Epilepsia Resistente a Medicamentos/cirurgia , Epilepsia Resistente a Medicamentos/diagnóstico por imagem , Epilepsia Resistente a Medicamentos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA